These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15041116

  • 1. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.
    von Keitz A, Rajfer J, Segal S, Murphy A, Denne J, Costigan T, Lockhart D, Beasley CM, Emmick JT.
    Eur Urol; 2004 Apr; 45(4):499-507; discussion 507-9. PubMed ID: 15041116
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A.
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [Abstract] [Full Text] [Related]

  • 3. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study.
    Lee J, Pommerville P, Brock G, Gagnon R, Mehta P, Krisdaphongs M, Chan M, Chan J, Dickson R.
    BJU Int; 2006 Sep; 98(3):623-9. PubMed ID: 16925764
    [Abstract] [Full Text] [Related]

  • 4. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY, Lee SW, Kim SW, Yang DY, Park NC, Min KS, Park K, Paick JS, Dyachkova Y, Dwight T, Lee MS.
    Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
    [Abstract] [Full Text] [Related]

  • 5. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
    Shabsigh R, Burnett AL, Eardley I, Sharlip ID, Ellsworth PI, Garcia CS, Natanegara F, Ahuja S.
    BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217
    [Abstract] [Full Text] [Related]

  • 6. [Tadalafil vs sildenafil patient preference in Spanish men with erectile dysfunction: results from an International Multicentric Study].
    Rodríguez Vela L, Lledó García E, Rajmil O, Mo D, Cassinello A, Casariego J.
    Actas Urol Esp; 2006 Jan; 30(1):67-79. PubMed ID: 16703733
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries.
    Mirone V, Costa P, Damber JE, Holmes S, Moncada I, Van Ahlen H, Wespes E, Cordell WH, Chan M, Lembo D, Varanese L.
    Eur Urol; 2005 Jun; 47(6):846-54; discussion 854. PubMed ID: 15925082
    [Abstract] [Full Text] [Related]

  • 8. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG, Aliotta P, Auerbach S, Barkin J, Lording D, Murdock M, Wilkins HJ, McBride TA, Colopy MW, Carson CC, Patient Response with Vardenafil in Sildenafil Non-Responders (PROVEN) Study Group.
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [Abstract] [Full Text] [Related]

  • 9. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners.
    Brock G, Chan J, Carrier S, Chan M, Salgado L, Klein AH, Lang C, Horner R, Gutkin S, Dickson R.
    BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989
    [Abstract] [Full Text] [Related]

  • 10. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
    Buvat J, Hatzichristou D, Maggi M, Farmer I, Martínez-Jabaloyas JM, Miller PJ, Schnetzler G.
    BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
    [Abstract] [Full Text] [Related]

  • 11. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.
    Dean J, Hackett GI, Gentile V, Pirozzi-Farina F, Rosen RC, Zhao Y, Warner MR, Beardsworth A.
    J Sex Med; 2006 Jul; 3(4):650-661. PubMed ID: 16839321
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST.
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [Abstract] [Full Text] [Related]

  • 13. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR, Campaña JMC, Ciutat LF, Miranda EF.
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [Abstract] [Full Text] [Related]

  • 14. Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment.
    Althof SE, O'Leary MP, Cappelleri JC, Crowley AR, Tseng LJ, Collins S.
    J Urol; 2006 Nov; 176(5):2132-7. PubMed ID: 17070276
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra) for erectile dysfunction.
    McCullough AR, Carson CC, Hatzichristou D.
    Urology; 2006 Sep; 68(3 Suppl):38-46. PubMed ID: 17011374
    [Abstract] [Full Text] [Related]

  • 16. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
    Eardley I, Wright P, MacDonagh R, Hole J, Edwards A.
    BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L, Slagter C, Slob AK, Hop WC.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):439-44. PubMed ID: 16965992
    [Abstract] [Full Text] [Related]

  • 19. The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study.
    Wespes E, Moncada I, Schmitt H, Jungwirth A, Chan M, Varanese L.
    BJU Int; 2007 Jan 01; 99(1):121-6. PubMed ID: 17227498
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS.
    Eur Urol; 2006 Aug 01; 50(2):351-9. PubMed ID: 16766116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.